Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma

키워드

참고문헌 (40)

1. Bruix J, "Prognostic prediction and treatment strategy in hepatocellular carcinoma", Hepatology, 35, pp.519~524 (2002)
2. Reding R, "Steroid-free liver transplantation in children", Lancet, 362, pp.2068~2070 (2003)
3. Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
4. Marsh JW, "The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study", Hepatology, 26, pp.444~450 (1997)
5. Zimmerman MA, "Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators", Arch Surg, 143, pp.182~188 (2008)
6. Gundisch S, "Glucocorticoids augment survival and proliferation of tumor cells", Anticancer Res, 32, pp.4251~4261 (2012)
7. Mazzaferro V, "Milan multicenter experience in liver transplantation for hepatocellular carcinoma", Transplant Proc, 26, pp.3557~3560 (1994)
8. Stegall MD, "Metabolic complications after liver transplantation: diabetes, hypercholesterolemia, hypertension, and obesity", Transplantation, 60, pp.1057~1060 (1995)
9. Fukumoto T, "Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions", Hepatology, 24, pp.1351~1354 (1996)
10. Marubashi S, "Steroid-free living-donor liver transplantation in adults", Transplantation, 80, pp.704~706 (2005)
11. Filipponi F, "Study of simulect-based, steroid-free immunosuppressive regimen in HCV+de novo liver transplant patients: preliminary results", Transplant Proc, 33, pp.3211~3212 (2001)
12. Figueras J, "Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients", Transplant Proc, 34, pp.1511~1513 (2002)
13. Kato T, "Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study", Transplant Proc, 37, pp.1217~1219 (2005)
14. Perkins J, "Adrenal failure in liver transplant patients: does steroidfree immunosuppression place recipients at risk for an adrenal crisis?", Liver Transpl, 12, pp.160~162 (2006)
15. Humar A, "Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes", Clin Transplant, 21, pp.526~531 (2007)
16. Klintmalm GB, "Corticosteroidfree immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study", Liver Transpl, 13, pp.1521~1531 (2007)
17. Foroncewicz B, "Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center", Transplant Proc, 41, pp.3103~3106 (2009)
18. Sen S, "Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression", Transpl Infect Dis, 12, pp.184~185 (2010)
19. Ju WQ, "Twenty-four hour steroid avoidance immunosuppressive regimen in liver transplant recipients", Exp Clin Transplant, 10, pp.258~262 (2012)
20. Hu AB, "Safety and efficacy of four steroid-minimization protocols in liver transplant recipients:3-year follow-up in a single center", J Dig Dis, 14, pp.38~44 (2013)
21. Xu X, "Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience", Hepatobiliary Pancreat Dis Int, 7, pp.465~470 (2008)
22. Mazzaferro V, "Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis", N Engl J Med, 334, pp.693~699 (1996)
23. Zheng S, "Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis", Liver Transpl, 12, pp.253~258 (2006)
24. Demetris AJ, "Banff schema for grading liver allograft rejection: an international consensus document", Hepatology, 25, pp.658~663 (1997)
25. Ormonde DG, "Banff schema for grading liver allograft rejection: utility in clinical practice", Liver Transpl Surg, 5, pp.261~268 (1999)
26. Ling Q, "Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population", J Hepatol, 58, pp.271~277 (2013)
27. Ling Q, "Major influence of renal function on hyperlipidemia after living donor liver transplantation", World J Gastroenterol, 18, pp.7033~7039 (2012)
28. Xu X, "A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation", Liver Int, 27, pp.816~824 (2007)
29. Taylor AL, "Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy", Crit Rev Oncol Hematol, 56, pp.23~46 (2005)
30. Rolles K, "A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin", Transplantation, 68, pp.1195~1198 (1999)
31. Marino IR, "Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients", Transplantation, 78, pp.886~891 (2004)
32. Gruttadauria S, "A safe immunosuppressive protocol in adult-to-adult living related liver transplantation", Transplant Proc, 38, pp.1106~1108 (2006)
33. Moench C, "Tacrolimus monotherapy without steroids after liver transplantation: a prospective randomized double-blinded placebo-controlled trial", Am J Transplant, 7, pp.1616~1623 (2007)
34. Kim JM, "Steroid withdrawal in adult liver transplantation:occurrence at a single center", Transplant Proc, 42, pp.4132~4136 (2010)
35. Cronstein BN, "A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1", Proc Natl Acad Sci U S A, 89, pp.9991~9995 (1992)
36. Brattsand R, "Cytokine modulation by glucocorticoids : mechanisms and actions in cellular studies", Aliment Pharmacol Ther, 10(2), pp.81~90 (1996)
37. Yazawa H, "Glucocorticoid hormone suppression of human neutrophil-mediated tumor cell cytostasis", Int J Cancer, 81, pp.74~80 (1999)
38. Marzano A, "Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence", Liver Transpl, 11, pp.402~409 (2005)
39. Roche B, "Treatment of hepatitis B and C after liver transplantation. Part 1: hepatitis B", Transpl Int, 17, pp.746~758 (2005)
40. Yi NJ, "Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation", Liver Transpl, 13, pp.451~458 (2007)

관련 논문AI추천